Innovus Pharma Initiates Primate Safety Studies of Its Products That Affect Premature Ejaculation and Penile Sensation
7/3/2013 8:06:37 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
LA JOLLA, Calif., July 3, 2013 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals Inc., ("Innovus Pharma") www.innovuspharma.com (OTCBB:INNV) today announced it started two studies in non-human primates to evaluate the safety of daily use of EjectDelay and CIRCUMserum.
Help employers find you! Check out all the jobs and post your resume.
comments powered by